Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Novo's CEO knows the drugmaker needs to build confidence

LONDON — Many investors were underwhelmed by Novo’s articulation of its strategy at the company’s capital markets day on Monday, and Mike Doustdar knows it. “In some ways, it's good that it's out ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 22 September →